Reduction of cerebrovascular and peripheral events with PCSK9 inhibitors: Does it just depend on the lowering of the low-density lipoprotein?

por Cesaro, Arturo, Acerbo, Vincenzo, Raucci, Giuseppe, Calabrò, Paolo
Publicado 2022

Understanding the role of coronary artery revascularization in patients with left ventricular dysfunction and multivessel disease

por Acerbo, Vincenzo, Cesaro, Arturo, Scherillo, Gianmaria, Signore, Giovanni, Rotolo, Francesco Paolo, De Michele, Gianantonio, Scialla, Francesco, Raucci, Giuseppe, Panico, Domenico, Fimiani, Fabio, Moscarella, Elisabetta, Gragnano, Felice, Calabrò, Paolo
Publicado 2023

Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options

por Cesaro, Arturo, De Michele, Gianantonio, Fimiani, Fabio, Acerbo, Vincenzo, Scherillo, Gianmaria, Signore, Giovanni, Rotolo, Francesco Paolo, Scialla, Francesco, Raucci, Giuseppe, Panico, Domenico, Gragnano, Felice, Moscarella, Elisabetta, Scudiero, Olga, Mennitti, Cristina, Calabrò, Paolo
Publicado 2023

Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Pr...

por Cesaro, Arturo, Acerbo, Vincenzo, Vetrano, Erica, Signore, Giovanni, Scherillo, Gianmaria, Rotolo, Francesco Paolo, De Michele, Gianantonio, Scialla, Francesco, Raucci, Giuseppe, Panico, Domenico, Gragnano, Felice, Moscarella, Elisabetta, Galiero, Raffaele, Caturano, Alfredo, Ruggiero, Roberto, Sasso, Ferdinando Carlo, Calabrò, Paolo
Publicado 2023